Results 21 to 30 of about 102,651 (313)

The use of anticoagulants in chronic kidney disease: Common point of view of cardiologists and nephrologists

open access: yesCardiology Journal, 2020
In patients diagnosed with chronic kidney disease (CKD), atrial fibrillation (AF) is associated with an increased risk of thromboembolism and stroke. Moreover, patients with CKD — especially those in end-stage renal disease — also present an increased ...
Justyna Domienik-Karłowicz   +4 more
doaj   +1 more source

The Prophylaxis of Venous Thromboembolism [PDF]

open access: yesDeutsches Ärzteblatt international, 2016
Venous thromboembolism (VTE) is the third most common cardiovascular condition, after myocardial infarction and stroke. Prophylactic measures in accordance with current guidelines can significantly reduce the risk of VTE and the associated morbidity and mortality.
Albrecht, Encke, Sylvia, Haas, Ina, Kopp
openaire   +2 more sources

Knowledge, Awareness and Risk of Occurrence of Venous Thromboembolism of Perinatal Women [PDF]

open access: yesKorean Journal of Women Health Nursing, 2019
PURPOSE: The purpose of this study is to identify knowledge, awareness, and risk of occurrence of venous thromboembolism among pregnant women. METHODS: Subjects were 106 pregnant women treated as inpatients and outpatients at a women's health ...
Eun Sook Kim, Hye Young Kim
doaj   +1 more source

Association of Antipsychotic Drugs with the Risk of Recurrent Venous Thromboembolism: A Retrospective Study of Data from a Japanese Inpatient Database

open access: yesDrugs - Real World Outcomes, 2023
Background Approximately a decade has passed since the addition of venous thromboembolism to the list of significant adverse reactions of antipsychotic drugs.
Hiroyuki Hashimoto   +4 more
doaj   +1 more source

Cancer and thrombosis: Managing the risks and approaches to thromboprophylaxis [PDF]

open access: yes, 2006
Patients with cancer are at increased risk of venous thromboembolism (VTE) compared with patients without cancer. This results from both the prothrombotic effects of the cancer itself and iatrogenic factors, such as chemotherapy, radiotherapy, indwelling
Erhard Hiller, Hiller, Erhard
core   +1 more source

Venous thromboembolism

open access: yesJournal of Postgraduate Medicine, 2009
Venous thromboembolism (VTE) has been a subject of great interest of late. Since Rudolph Virchow described the famous Virchow's triad in 1856, there have been rapid strides in the understanding of the pathogenesis and factors responsible for it. Discovery of various thrombophilic factors, both primary and acquired, in the last
Dutta, T.K., Venugopal, V.
openaire   +4 more sources

Omalizumab as a Provoking Factor for Venous Thromboembolism

open access: yesDrug Target Insights, 2019
A 43-year-old man with a history of severe extrinsic allergic asthma treated with once-monthly omalizumab (600 mg) for the last 15 months. He presented to the emergency room with a 2-week history of right lower limb pain and chest pleuritic pain ...
Crhistian-Mario Oblitas   +4 more
doaj   +1 more source

DEEP VEIN THROMBOSIS AND RECURENT PULMONARY EMBOLISM IN A PATIENT WITH THROMBOPHILIC MUTATIONS AND GENERALIZED PSORIASIS: A CASE REPORT

open access: yesSanamed, 2020
Introduction: Genetic risk factors that increase venous thromboembolism risk are disorders in the synthesis or activity of coagulation factors. Factor V Leiden, prothrombin (20210-A), antithrombin deficiency, protein C and protein S deficiency, and ...
Marjan Nove Baloski   +9 more
doaj   +1 more source

Electronic health record risk-stratification tool reduces venous thromboembolism events in surgical patients

open access: yesSurgery Open Science, 2022
Background: Venous thromboembolism is a preventable cause of morbidity and mortality after surgery. To ensure that patients receive appropriate venous thromboembolism chemoprophylaxis, a nonmandatory risk-stratification tool based on patient clinical ...
Radhika Rastogi, MD   +5 more
doaj   +1 more source

Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials [PDF]

open access: yes, 2012
Background - It has been suggested that statins substantially reduce the risk of venous thromboembolic events. We sought to test this hypothesis by performing a meta-analysis of both published and unpublished results from randomised trials of statins.
Jacquet Hervet, Michel   +134 more
core   +1 more source

Home - About - Disclaimer - Privacy